About this Journal Submit a Manuscript Table of Contents
Journal of Allergy
Volume 2013 (2013), Article ID 672381, 9 pages
http://dx.doi.org/10.1155/2013/672381
Review Article

An Important Role of Blood and Lymphatic Vessels in Inflammation and Allergy

Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Wolfgang Pauli-Strasse 10, HCI H303, 8093 Zurich, Switzerland

Received 9 September 2012; Revised 4 December 2012; Accepted 19 December 2012

Academic Editor: Alison Thorburn

Copyright © 2013 Silvana Zgraggen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Galli, M. Tsai, and A. M. Piliponsky, “The development of allergic inflammation,” Nature, vol. 454, no. 7203, pp. 445–454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Carmeliet, “Angiogenesis in health and disease,” Nature Medicine, vol. 9, no. 6, pp. 653–660, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Karpanen and K. Alitalo, “Molecular biology and pathology of lymphangiogenesis,” Annual Review of Pathology, vol. 3, pp. 367–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Hirakawa, S. Kodama, R. Kunstfeld, K. Kajiya, L. F. Brown, and M. Detmar, “VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis,” Journal of Experimental Medicine, vol. 201, no. 7, pp. 1089–1099, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Mumprecht and M. Detmar, “Lymphangiogenesis and cancer metastasis,” Journal of Cellular and Molecular Medicine, vol. 13, no. 8, pp. 1405–1416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Detmar, L. F. Brown, K. P. Claffey et al., “Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis,” Journal of Experimental Medicine, vol. 180, no. 3, pp. 1141–1146, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Danese, M. Sans, C. de la Motte et al., “Angiogenesis as a novel component of inflammatory bowel disease pathogenesis,” Gastroenterology, vol. 130, no. 7, pp. 2060–2073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Baluk, T. Tammela, E. Ator et al., “Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 247–257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Thairu, S. Kiriakidis, P. Dawson, et al., “Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience,” Angiogenesis, vol. 14, no. 3, pp. 223–234, 2011. View at Publisher · View at Google Scholar
  10. M. J. Karkkainen and T. V. Petrova, “Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis,” Oncogene, vol. 19, no. 49, pp. 5598–5605, 2000. View at Scopus
  11. C. Norrmén, T. Tammela, T. V. Petrova, and K. Alitalo, “Biological basis of therapeutic lymphangiogenesis,” Circulation, vol. 123, no. 12, pp. 1335–1351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. I. M. Braverman, “Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states,” Journal of Investigative Dermatology, vol. 93, supplement 2, pp. 2S–9S, 1989. View at Scopus
  13. M. Detmar and S. Hirakawa, “Vascular Biology,” in Dermatology, pp. 1679–1689, 3rd edition, 2012.
  14. R. Huggenberger and M. Detmar, “The cutaneous vascular system in chronic skin inflammation,” Journal of Investigative Dermatology, vol. 15, no. 1, pp. 24–32, 2011. View at Publisher · View at Google Scholar
  15. M. Skobe and M. Detmar, “Structure, function, and molecular control of the skin lymphatic system,” Journal of Investigative Dermatology Symposium Proceedings, vol. 5, no. 1, pp. 14–19, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Zanini, A. Chetta, A. S. Imperatori, A. Spanevello, and D. Olivieri, “The role of the bronchial microvasculature in the airway remodelling in asthma and COPD,” Respiratory Research, vol. 11, article 132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. J. Gordon, N. W. Gale, and N. L. Harvey, “Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels,” Developmental Dynamics, vol. 237, no. 7, pp. 1901–1909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kambouchner and J. F. Bernaudin, “Intralobular pulmonary lymphatic distribution in normal human lung using D2-40 antipodoplanin immunostaining,” Journal of Histochemistry and Cytochemistry, vol. 57, no. 7, pp. 643–648, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Sozio, A. Rossi, E. Weber, et al., “Morphometric analysis of intralobular, interlobular and pleural lymphatics in normal human lung,” Journal of Anatomy, vol. 220, no. 4, pp. 396–404, 2012. View at Publisher · View at Google Scholar
  20. J. S. Pober and W. C. Sessa, “Evolving functions of endothelial cells in inflammation,” Nature Reviews Immunology, vol. 7, no. 10, pp. 803–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. R. Jackson, M. P. Seed, C. H. Kircher, D. A. Willoughby, and J. D. Winkler, “The codependence of angiogenesis and chronic inflammation,” The FASEB Journal, vol. 11, no. 6, pp. 457–465, 1997. View at Scopus
  22. D. Ribatti, I. Puxeddu, E. Crivellato, B. Nico, A. Vacca, and F. Levi-Schaffer, “Angiogenesis in asthma,” Clinical and Experimental Allergy, vol. 39, no. 12, pp. 1815–1821, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, H. Matsuo, and E. Morita, “Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis,” Archives of Dermatological Research, vol. 297, no. 9, pp. 425–429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Ohl, M. Mohaupt, N. Czeloth et al., “CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions,” Immunity, vol. 21, no. 2, pp. 279–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Kunstfeld, S. Hirakawa, Y. K. Hong et al., “Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia,” Blood, vol. 104, no. 4, pp. 1048–1057, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Kajiya and M. Detmar, “An important role of lymphatic vessels in the control of UVB-induced edema formation and inflammation,” Journal of Investigative Dermatology, vol. 126, no. 4, pp. 920–922, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Zhang, Y. Lu, S. T. Proulx et al., “Increased lymphangiogenesis in joints of mice with inflammatory arthritis,” Arthritis Research and Therapy, vol. 9, no. 6, article R118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nature Medicine, vol. 9, no. 6, pp. 669–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. van Oosterom, and E. A. de Bruijn, “Vascular endothelial growth factor and angiogenesis,” Pharmacological Reviews, vol. 56, no. 4, pp. 549–580, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. H. Adams and K. Alitalo, “Molecular regulation of angiogenesis and lymphangiogenesis,” Nature Reviews Molecular Cell Biology, vol. 8, no. 6, pp. 464–478, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. G. H. Fong, J. Rossant, M. Gertsenstein, and M. L. Breitman, “Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium,” Nature, vol. 376, no. 6535, pp. 66–70, 1995. View at Scopus
  32. S. Hiratsuka, O. Minowa, J. Kuno, T. Noda, and M. Shibuya, “Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9349–9354, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Joukov, T. Sorsa, V. Kumar et al., “Proteolytic processing regulates receptor specificity and activity of VEGF-C,” The EMBO Journal, vol. 16, no. 13, pp. 3898–3911, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Mäkinen, T. Veikkola, S. Mustjoki et al., “Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3,” The EMBO Journal, vol. 20, no. 17, pp. 4762–4773, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Kriehuber, S. Breiteneder-Geleff, M. Groeger et al., “Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages,” Journal of Experimental Medicine, vol. 194, no. 6, pp. 797–808, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Huggenberger, S. S. Siddiqui, D. Brander et al., “An important role of lymphatic vessel activation in limiting acute inflammation,” Blood, vol. 117, no. 17, pp. 4667–4678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Huggenberger, S. Ullmann, S. T. Proulx, B. Pytowski, K. Alitalo, and M. Detmar, “Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation,” Journal of Experimental Medicine, vol. 207, no. 10, pp. 2255–2269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Ristimäki, K. Narko, B. Enholm, V. Joukov, and K. Alitalo, “Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C,” Journal of Biological Chemistry, vol. 273, no. 14, pp. 8413–8418, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Baluk, L. C. Yao, J. Feng et al., “TNF-α drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice,” Journal of Clinical Investigation, vol. 119, no. 10, pp. 2954–2964, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Cursiefen, L. Chen, L. P. Borges et al., “VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment,” Journal of Clinical Investigation, vol. 113, no. 7, pp. 1040–1050, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. L. S. Chan, “Atopic dermatitis in 2008,” Current Directions in Autoimmunity, vol. 10, pp. 76–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Yano, H. Oura, and M. Detmar, “Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage,” Journal of Investigative Dermatology, vol. 118, no. 5, pp. 800–805, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. L. F. Brown, T. J. Harrist, K. T. Yeo et al., “Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme,” Journal of Investigative Dermatology, vol. 104, no. 5, pp. 744–749, 1995. View at Scopus
  44. M. Detmar, “The role of VEGF and thrombospondins in skin angiogenesis,” Journal of Dermatological Science, vol. 24, supplement 1, pp. S78–S84, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Bhushan, B. McLaughlin, J. B. Weiss, and C. E. M. Griffiths, “Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis,” British Journal of Dermatology, vol. 141, no. 6, pp. 1054–1060, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Zenz, R. Eferl, L. Kenner et al., “Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins,” Nature, vol. 437, no. 7057, pp. 369–375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. S. P. Raychaudhuri, M. Sanyal, S. K. Raychaudhuri, S. Dutt, and E. M. Farber, “Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation,” British Journal of Dermatology, vol. 144, no. 5, pp. 931–939, 2001. View at Publisher · View at Google Scholar
  48. Y. P. Xia, B. Li, D. Hylton, M. Detmar, G. D. Yancopoulos, and J. S. Rudge, “Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis,” Blood, vol. 102, no. 1, pp. 161–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Halin, H. Fahrngruber, J. G. Meingassner et al., “Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor,” American Journal of Pathology, vol. 173, no. 1, pp. 265–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. M. P. Schön, “Animal models of psoriasis: a critical appraisal,” Experimental Dermatology, vol. 17, no. 8, pp. 703–712, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. L. van der Fits, S. Mourits, J. S. A. Voerman et al., “Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis,” Journal of Immunology, vol. 182, no. 9, pp. 5836–5845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. C. E. Brewster, P. H. Howarth, R. Djukanovic, J. Wilson, S. T. Holgate, and W. R. Roche, “Myofibroblasts and subepithelial fibrosis in bronchial asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 3, no. 5, pp. 507–511, 1990. View at Scopus
  53. W. R. Roche, R. Beasley, J. H. Williams, and S. T. Holgate, “Subepithelial fibrosis in the bronchi of asthmatics,” The Lancet, vol. 1, no. 8637, pp. 520–524, 1989. View at Scopus
  54. B. E. Orsida, X. Li, B. Hickey, F. Thien, J. W. Wilson, and E. H. Walters, “Vascularity in asthmatic airways: relation to inhaled steroid dose,” Thorax, vol. 54, no. 4, pp. 289–295, 1999. View at Scopus
  55. A. Chetta, A. Zanini, O. Torre, and D. Olivieri, “Vascular remodelling and angiogenesis in asthma: Morphological aspects and pharmacological modulation,” Inflammation and Allergy, vol. 6, no. 1, pp. 41–45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Hashimoto, H. Tanaka, and S. Abe, “Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD,” Chest, vol. 127, no. 3, pp. 965–972, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. M. S. Dunill, “The pathology of asthma, with special reference to changes in the bronchial mucosa,” Journal of Clinical Pathology, vol. 13, pp. 27–33, 1960. View at Scopus
  58. K. Asai, H. Kanazawa, K. Otani, S. Shiraishi, K. Hirata, and J. Yoshikawa, “Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects,” Journal of Allergy and Clinical Immunology, vol. 110, no. 4, pp. 571–575, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Hoshino, Y. Nakamura, and Q. A. Hamid, “Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma,” Journal of Allergy and Clinical Immunology, vol. 107, no. 6, pp. 1034–1038, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Zanini, A. Chetta, M. Saetta et al., “Chymase-positive mast cells play a role in the vascular component of airway remodeling inasthma,” Journal of Allergy and Clinical Immunology, vol. 120, no. 2, pp. 329–333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. B. L. Gruber, M. J. Marchese, and R. Kew, “Angiogenic factors stimulate mast-cell migration,” Blood, vol. 86, no. 7, pp. 2488–2493, 1995. View at Scopus
  62. M. Detmar, L. F. Brown, M. P. Schön et al., “Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice,” Journal of Investigative Dermatology, vol. 111, no. 1, pp. 1–6, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. B. Barleon, S. Sozzani, D. Zhou, H. A. Weich, A. Mantovani, and D. Marmé, “Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1,” Blood, vol. 87, no. 8, pp. 3336–3343, 1996. View at Scopus
  64. C. Feistritzer, N. C. Kaneider, D. H. Sturn, B. A. Mosheimer, C. M. Kähler, and C. J. Wiedermann, “Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils,” American Journal of Respiratory Cell and Molecular Biology, vol. 30, no. 5, pp. 729–735, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Detoraki, R. I. Staiano, F. Granata et al., “Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects,” Journal of Allergy and Clinical Immunology, vol. 123, no. 5, pp. 1142.e5–1149.e5, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. D. M. McDonald, “Angiogenesis and remodeling of airway vasculature in chronic inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, pp. S39–S45, 2001. View at Scopus
  67. K. F. Chung, D. F. Rogers, P. J. Barnes, and T. W. Evans, “The role of increased airway microvascular permeability and plasma exudation in asthma,” European Respiratory Journal, vol. 3, no. 3, pp. 329–337, 1990. View at Scopus
  68. S. El-Chemaly, G. Pacheco-Rodriguez, Y. Ikeda, D. Malide, and J. Moss, “Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease,” Lymphatic Research and Biology, vol. 7, no. 4, pp. 197–203, 2009. View at Scopus
  69. S. J. Leibovich, P. J. Polverini, H. M. Shepard, D. M. Wiseman, V. Shively, and N. Nuseir, “Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α,” Nature, vol. 329, no. 6140, pp. 630–632, 1987. View at Scopus
  70. M. Frater-Schroder, W. Risau, and R. Hallmann, “Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 15, pp. 5277–5281, 1987. View at Scopus
  71. L. F. Fajardo, H. H. Kwan, J. Kowalski, S. D. Prionas, and A. C. Allison, “Dual role of tumor necrosis factor-α in angiogenesis,” American Journal of Pathology, vol. 140, no. 3, pp. 539–544, 1992. View at Scopus
  72. J. Jagielska, P. R. Kapopara, G. Salguero, et al., “Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells,” Arteriosclerosis, Thrombosis and Vascular Biology, vol. 32, no. 5, pp. 1280–1288, 2012. View at Publisher · View at Google Scholar
  73. D. BenEzra, I. Hemo, and G. Maftzir, “In vivo angiogenic activity of interleukins,” Archives of Ophthalmology, vol. 108, no. 4, pp. 573–576, 1990. View at Scopus
  74. F. Cozzolino, M. Torcia, D. Aldinucci et al., “Interleukin 1 is an autocrine regulator of human endothelial cell growth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 17, pp. 6487–6491, 1990. View at Scopus
  75. A. E. Koch, P. J. Polverini, S. L. Kunkel et al., “Interleukin-8 as a macrophage-derived mediator of angiogenesis,” Science, vol. 258, no. 5089, pp. 1798–1801, 1992. View at Scopus
  76. C. L. Addison, T. O. Daniel, M. D. Burdick et al., “The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity,” Journal of Immunology, vol. 165, no. 9, pp. 5269–5277, 2000. View at Scopus
  77. A. L. Angiolillo, H. Kanegane, C. Sgadari, G. H. Reaman, and G. Tosato, “Interleukin-15 promotes angiogenesis in vivo,” Biochemical and Biophysical Research Communications, vol. 233, no. 1, pp. 231–237, 1997. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Numasaki, J. I. Fukushi, M. Ono et al., “Interleukin-17 promotes angiogenesis and tumor growth,” Blood, vol. 101, no. 7, pp. 2620–2627, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. C. C. Park, J. C. M. Morel, M. A. Amin, M. A. Connors, L. A. Harlow, and A. E. Koch, “Evidence of IL-18 as a novel angiogenic mediator,” Journal of Immunology, vol. 167, no. 3, pp. 1644–1653, 2001. View at Scopus
  80. M. A. Amin, B. J. Rabquer, P. J. Mansfield et al., “Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases,” Annals of the Rheumatic Diseases, vol. 69, no. 12, pp. 2204–2212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. C. M. Coughlin, K. E. Salhany, M. Wysocka et al., “Interleukin-12, and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis,” Journal of Clinical Investigation, vol. 101, no. 6, pp. 1441–1452, 1998. View at Scopus
  82. R. Cao, J. Farnebo, M. Kurimoto, and Y. Cao, “Interleukin-18 acts as an angiogenesis and tumor suppressor,” The FASEB Journal, vol. 13, no. 15, pp. 2195–2202, 1999. View at Scopus
  83. R. M. Strieter, P. J. Polverini, S. L. Kunkel et al., “The functional role of the ELR motif in CXC chemokine-mediated angiogenesis,” Journal of Biological Chemistry, vol. 270, no. 45, pp. 27348–27357, 1995. View at Publisher · View at Google Scholar · View at Scopus
  84. E. C. Keeley, B. Mehrad, and R. M. Strieter, “Chemokines as mediators of neovascularization,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 11, pp. 1928–1936, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Fan, J. Ye, F. Shen et al., “Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 1, pp. 90–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. M. V. Volin, J. M. Woods, M. A. Amin, M. A. Connors, L. A. Harlow, and A. E. Koch, “Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis,” American Journal of Pathology, vol. 159, no. 4, pp. 1521–1530, 2001. View at Scopus
  87. R. Salcedo, K. Wasserman, H. A. Young et al., “Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells. In vivo neovascularization induced by stromal-derived factor-1α,” American Journal of Pathology, vol. 154, no. 4, pp. 1125–1135, 1999. View at Scopus
  88. I. Kryczek, N. Frydman, F. Gaudin et al., “The chemokine SDF-1/CXCL12 contributes to T lymphocyte recruitment in human pre-ovulatory follicles and coordinates with lymphocytes to increase granulosa cell survival and embryo quality,” American Journal of Reproductive Immunology, vol. 54, no. 5, pp. 270–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. R. Salcedo, M. L. Ponce, H. A. Young et al., “Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression,” Blood, vol. 96, no. 1, pp. 34–40, 2000. View at Scopus
  90. K. Ebnet and D. Vestweber, “Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines,” Histochemistry and Cell Biology, vol. 112, no. 1, pp. 1–23, 1999. View at Publisher · View at Google Scholar · View at Scopus